Literature DB >> 22884844

Effects of R92 mutations in mouse cardiac troponin T are influenced by changes in myosin heavy chain isoform.

Steven J Ford1, Ranganath Mamidi, Jesus Jimenez, Jil C Tardiff, Murali Chandra.   

Abstract

One limitation in understanding how different familial hypertrophic cardiomyopathy (FHC)-related mutations lead to divergent cardiac phenotypes is that such mutations are often studied in transgenic (TG) mouse hearts which contain a fast cycling myosin heavy chain isoform (α-MHC). However, the human heart contains a slow cycling MHC isoform (β-MHC). Given the physiological significance of MHC-troponin interplay effects on cardiac contractile function, we hypothesized that cardiac troponin T (cTnT) mutation-mediated effects on contractile function depend on the type of MHC isoform present in the sarcomere. We tested our hypothesis using two variants of cTnT containing mutations at FHC hotspot R92 (R92L or R92Q), expressed against either an α-MHC or β-MHC background in TG mouse hearts. One finding from our study was that R92L attenuated the length-dependent increase in tension and abolished the length-dependent increase in myofilament Ca(2+) sensitivity only when β-MHC was present. In addition, α- and β-MHC isoforms differentially affected how R92 mutations altered crossbridge (XB) recruitment dynamics. For example, the rate of XB recruitment was faster in R92L or R92Q fibers when β-MHC was present, but was unaffected when α-MHC was present. The R92Q mutation sped XB detachment in the presence of β-MHC, but not in the presence of α-MHC. R92Q affected the XB strain-dependent influence on XB recruitment dynamics, an effect not observed for R92L. Our findings have major implications for understanding not only the divergent effects of R92 mutations on cardiac phenotype, but also the distinct effects of MHC isoforms in determining the outcome of mutations in cTnT. Published by Elsevier Ltd.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22884844      PMCID: PMC3442937          DOI: 10.1016/j.yjmcc.2012.07.018

Source DB:  PubMed          Journal:  J Mol Cell Cardiol        ISSN: 0022-2828            Impact factor:   5.000


  27 in total

1.  Myosin heavy chain isoform expression in the failing and nonfailing human heart.

Authors:  S Miyata; W Minobe; M R Bristow; L A Leinwand
Journal:  Circ Res       Date:  2000-03-03       Impact factor: 17.367

Review 2.  Regulation of contraction in striated muscle.

Authors:  A M Gordon; E Homsher; M Regnier
Journal:  Physiol Rev       Date:  2000-04       Impact factor: 37.312

3.  Cooperative activation in cardiac muscle: impact of sarcomere length.

Authors:  David P Dobesh; John P Konhilas; Pieter P de Tombe
Journal:  Am J Physiol Heart Circ Physiol       Date:  2002-03       Impact factor: 4.733

4.  Disease-causing mutations in cardiac troponin T: identification of a critical tropomyosin-binding region.

Authors:  T Palm; S Graboski; S E Hitchcock-DeGregori; N J Greenfield
Journal:  Biophys J       Date:  2001-11       Impact factor: 4.033

Review 5.  Frank-Starling law of the heart and the cellular mechanisms of length-dependent activation.

Authors:  John P Konhilas; Thomas C Irving; Pieter P de Tombe
Journal:  Pflugers Arch       Date:  2002-11-01       Impact factor: 3.657

6.  Interpreting cardiac muscle force-length dynamics using a novel functional model.

Authors:  Kenneth B Campbell; Murali Chandra; Robert D Kirkpatrick; Bryan K Slinker; William C Hunter
Journal:  Am J Physiol Heart Circ Physiol       Date:  2004-04       Impact factor: 4.733

7.  Hypertrophic cardiomyopathy: distribution of disease genes, spectrum of mutations, and implications for a molecular diagnosis strategy.

Authors:  Pascale Richard; Philippe Charron; Lucie Carrier; Céline Ledeuil; Theary Cheav; Claire Pichereau; Abdelaziz Benaiche; Richard Isnard; Olivier Dubourg; Marc Burban; Jean-Pierre Gueffet; Alain Millaire; Michel Desnos; Ketty Schwartz; Bernard Hainque; Michel Komajda
Journal:  Circulation       Date:  2003-04-21       Impact factor: 29.690

8.  Correlation of molecular and functional effects of mutations in cardiac troponin T linked to familial hypertrophic cardiomyopathy: an integrative in silico/in vitro approach.

Authors:  Edward P Manning; Pia J Guinto; Jil C Tardiff
Journal:  J Biol Chem       Date:  2012-02-13       Impact factor: 5.157

9.  Cardiac troponin T mutations: correlation between the type of mutation and the nature of myofilament dysfunction in transgenic mice.

Authors:  D E Montgomery; J C Tardiff; M Chandra
Journal:  J Physiol       Date:  2001-10-15       Impact factor: 5.182

10.  Prevalence and spectrum of thin filament mutations in an outpatient referral population with hypertrophic cardiomyopathy.

Authors:  Sara L Van Driest; Erik G Ellsworth; Steve R Ommen; A Jamil Tajik; Bernard J Gersh; Michael J Ackerman
Journal:  Circulation       Date:  2003-07-14       Impact factor: 29.690

View more
  34 in total

1.  Disrupted mechanobiology links the molecular and cellular phenotypes in familial dilated cardiomyopathy.

Authors:  Sarah R Clippinger; Paige E Cloonan; Lina Greenberg; Melanie Ernst; W Tom Stump; Michael J Greenberg
Journal:  Proc Natl Acad Sci U S A       Date:  2019-08-19       Impact factor: 11.205

2.  Instability in the central region of tropomyosin modulates the function of its overlapping ends.

Authors:  Ranganath Mamidi; Mariappan Muthuchamy; Murali Chandra
Journal:  Biophys J       Date:  2013-11-05       Impact factor: 4.033

3.  L71F mutation in rat cardiac troponin T augments crossbridge recruitment and detachment dynamics against α-myosin heavy chain, but not against β-myosin heavy chain.

Authors:  Sherif M Reda; Sampath K Gollapudi; Murali Chandra
Journal:  J Muscle Res Cell Motil       Date:  2016-12-14       Impact factor: 2.698

Review 4.  Research priorities in sarcomeric cardiomyopathies.

Authors:  Jolanda van der Velden; Carolyn Y Ho; Jil C Tardiff; Iacopo Olivotto; Bjorn C Knollmann; Lucie Carrier
Journal:  Cardiovasc Res       Date:  2015-01-28       Impact factor: 10.787

5.  The functional effect of dilated cardiomyopathy mutation (R144W) in mouse cardiac troponin T is differently affected by α- and β-myosin heavy chain isoforms.

Authors:  Sampath K Gollapudi; Jil C Tardiff; Murali Chandra
Journal:  Am J Physiol Heart Circ Physiol       Date:  2015-02-13       Impact factor: 4.733

6.  Sex dimorphisms of crossbridge cycling kinetics in transgenic hypertrophic cardiomyopathy mice.

Authors:  Camille L Birch; Samantha M Behunin; Marissa A Lopez-Pier; Christiane Danilo; Yulia Lipovka; Chandra Saripalli; Henk Granzier; John P Konhilas
Journal:  Am J Physiol Heart Circ Physiol       Date:  2016-05-06       Impact factor: 4.733

7.  In situ time-resolved FRET reveals effects of sarcomere length on cardiac thin-filament activation.

Authors:  King-Lun Li; Daniel Rieck; R John Solaro; Wenji Dong
Journal:  Biophys J       Date:  2014-08-05       Impact factor: 4.033

8.  Liver Kinase B1 complex acts as a novel modifier of myofilament function and localizes to the Z-disk in cardiac myocytes.

Authors:  Samantha M Behunin; Marissa A Lopez-Pier; Rachel M Mayfield; Christiane A Danilo; Yulia Lipovka; Camille Birch; Sarah Lehman; Jil C Tardiff; Carol C Gregorio; John P Konhilas
Journal:  Arch Biochem Biophys       Date:  2016-03-10       Impact factor: 4.013

9.  Elevated rates of force development and MgATP binding in F764L and S532P myosin mutations causing dilated cardiomyopathy.

Authors:  Bradley M Palmer; Joachim P Schmitt; Christine E Seidman; J G Seidman; Yuan Wang; Stephen P Bell; Martin M Lewinter; David W Maughan
Journal:  J Mol Cell Cardiol       Date:  2013-01-08       Impact factor: 5.000

10.  Identification of two new regions in the N-terminus of cardiac troponin T that have divergent effects on cardiac contractile function.

Authors:  Ranganath Mamidi; Sri Lakshmi Mallampalli; David F Wieczorek; Murali Chandra
Journal:  J Physiol       Date:  2012-12-03       Impact factor: 5.182

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.